$CRMD 4/A SEC Filings

Filed On	Filing
08 Sep 2025	Form 4/A: Hurlburt Elizabeth, Chief Operating Officer Gave up 8,424 shares to cover exercise price or tax ($125K)
08 Sep 2025	Form 4/A: Zelnick Kaufman Beth, Chief Legal Officer Gave up 8,880 shares to cover exercise price or tax ($132K)
18 Dec 2024	Form 4/A: Zelnick Kaufman Beth, Chief Legal Officer Gave up 6,044 shares to cover exercise price or tax ($53K)
18 Jan 2024	Form 4/A: Masson-Hurlburt Elizabeth, EVP, Head of Clinical Ops. Holds 45,397 shares of Common Stock
18 May 2023	Form 4/A: Costa Paulo F, Director Bought 10,000 shares ($46.5K)
18 May 2023	Form 4/A: Dunton Alan W, Director Bought 3,000 shares ($13K)
18 May 2023	Form 4/A: Stewart Robert A, Director Bought 10,000 shares ($43.7K)
18 May 2023	Form 4/A: Todisco Joseph, Director Bought 5,000 shares ($22.9K)
20 Feb 2020	Form 4/A: Dillione Janet, Director Granted 1,706 Phantom Stock
09 May 2019	Form 4/A: Dunton Alan W, Director Granted 20,000 Stock Option (Right to Buy Common Stock)
04 Apr 2019	Form 4/A: Kaplan Myron, Director Holds 98,734 shares of Common Stock
30 Nov 2018	Form 4/A: Kaplan Myron, Director Received 22,000 shares as a grant or award · Granted 40,000 Stock Option (Right to Buy Common STock)
30 Nov 2018	Form 4/A: Dillione Janet, Director Granted 6,637 Phantom Stock ($7.5K)
30 Nov 2018	Form 4/A: Gelbfish Gary A., Director Received 10,000 shares as a grant or award
30 Nov 2018	Form 4/A: Khan Mehmood, Director Received 12,500 shares as a grant or award
30 Nov 2018	Form 4/A: Lefkowitz Steven W, Director Received 10,000 shares as a grant or award
30 Nov 2018	Form 4/A: Gelbfish Gary A., Director Disposed of 1,000,000 Series A Common Stock Warrant (Other Transaction) · Received 1,000,000 shares by exercise or conversion ($1.05M) · Gave up 468,750 shares to cover exercise price or tax ($1.05M)
30 Nov 2018	Form 4/A: Dillione Janet, Director Received 14,000 shares as a grant or award · Granted 40,000 Stock Option (Right to Buy Common Stock)
30 Nov 2018	Form 4/A: Lefkowitz Steven W, Director Received 16,000 shares as a grant or award · Granted 40,000 Stock Option (Right to Buy Common Stock)
27 Nov 2018	Form 4/A: Kaplan Myron, Director Received 10,000 shares as a grant or award

Comments